Modern breast biopsy devices represent sophisticated precision medical systems integrating image-guided navigation, high-precision localization, minimally invasive tissue sampling and intelligent control. Evolving from basic puncture instruments into multidisciplinary diagnostic platforms, their core structural design and working principles govern procedural accuracy, clinical safety and operational efficiency.

Image-Guidance and Localization System: the "Eyes" and Navigation Core of Equipment

As the most critical component, this subsystem enables real-time lesion visualization and targeted needle placement, categorized into three mainstream modalities based on imaging mechanisms:

Ultrasound-guided SystemThe most widely applied and flexible guidance solution equipped with high-frequency linear transducers (7.5–15 MHz) to generate real-time dynamic 2D or 3D sonographic images. Its radiation-free property, multi-plane scanning capability and clear needle-track visualization render it ideal for palpable or sonographically visible breast masses. Advanced configurations incorporate elastography and contrast-enhanced ultrasound to facilitate differential diagnosis of benign and malignant lesions.

Stereotactic X-ray Guidance SystemThe gold standard for sampling mammographically detected microcalcifications invisible on ultrasound. Composed of a digital mammography unit, compression paddles and computerized positioning hardware, it acquires two projection images at ±15°. The system calculates precise three-dimensional lesion coordinates along X, Y and Z axes to direct needle access with submillimeter-level accuracy.

MRI-guided Biopsy SystemReserved exclusively for lesions only identifiable on contrast-enhanced MRI scans. It requires an open-bore MRI scanner and dedicated non-ferromagnetic biopsy kits consisting of localization frames, specialized surface coils and titanium-alloy biopsy needles. Patients lie prone with breasts suspended inside customized coils; lesion targeting is achieved via side-by-side comparison of pre- and post-contrast MRI sequences. Despite sophisticated engineering and high procurement cost, it is indispensable for high-risk population screening and preoperative evaluation before breast-conserving surgery.

Biopsy Execution & Specimen Harvesting System: the Functional "Hands" and Cutting Component

Responsible for controlled tissue incision and specimen retrieval, this unit centers on the main drive console and mechanical assemblies powering biopsy needle operation.

Main Vacuum-Assisted Biopsy (VAB) ConsoleThe dominant high-end platform built with an embedded negative-pressure vacuum pump and rotary drive motor. During operation, the pump generates constant negative pressure (−20 to −30 kPa) to draw target tissue into the needle's sampling notch; an integrated high-speed rotary cutter (1,000–1,500 RPM) cleanly transects captured tissue and transports specimens via internal lumens into an external collection chamber. Multiple sequential samples can be obtained through a single skin puncture.

Drive and Transmission MechanismTransmits power from the main unit to biopsy needles via precision gear trains, drive shafts and clutches to deliver fast, stable and reproducible cutting motion. Premium devices support selectable cutting modes including single-shot, continuous cut and oscillatory cut to accommodate tissue of varying consistencies.

Single-Use Biopsy/Coring Needle (Disposable Consumable Core)Constructed from an introducer trocar, outer cannula with a tissue sampling slot and inner rotary cutting blade. Available in standard gauge sizes ranging from 8G to 14G with configurable sampling notch lengths (10–30 mm) tailored to lesion dimension. Raw material selection, cutting sharpness and structural design directly determine specimen integrity and iatrogenic tissue trauma.

Intelligent Control & Human-Machine Interaction Platform: the Device's "Brain" and Operating Interface

Digitized and highly integrated modern hardware leverages intelligent software to streamline workflow and strengthen procedural safety.

Control Software & Graphical User InterfaceA touchscreen-based centralized dashboard consolidates full operational controls: vacuum pressure adjustment, cutting speed modulation, forward/retreat needle programming and real-time specimen tally. Preloaded clinical preset protocols (microcalcification biopsy, focal lesion excision etc.) and automatic procedural log archiving are standard built-in functions.

Safety Monitoring and Closed-Loop Feedback SystemMultiple built-in sensors continuously monitor core parameters including vacuum level, motor load current and needle tip position. The unit triggers instant audible/visual alerts and automatic protective shutdown upon malfunctions such as lumen occlusion, pressure loss or motor overload. Certain premium versions feature tactile pressure feedback to alert operators when the needle tip contacts dense fibrotic tissue or calcified foci.

Multi-Modality Image Fusion & Navigation SoftwareHigh-tier systems fuse real-time biopsy localization coordinates with preoperative 3D volumetric scans from MRI or CT to enable multimodal image-guided routing and optimized puncture trajectory planning for anatomically complex lesions.

Auxiliary Supporting Subsystems

Complementary components ensure full procedural integrity, including specimen collection accessories (filtration screens, aliquot cassettes), sterile drape barrier kits and deployable tissue marker clip dispensers. Metallic markers are implanted into post-biopsy resection cavities to serve as radiographic landmarks for subsequent definitive surgery or long-term imaging surveillance.

Summary

State-of-the-art breast biopsy instruments represent cross-disciplinary engineering achievements combining mechanical design, medical imaging, advanced material science and computer programming. Developed around core design tenets of precision, minimal invasiveness, high efficiency and patient safety, coordinated operation of all subsystems has transformed breast cancer diagnosis from traditional open surgical biopsy into an era of accurate minimally invasive sampling, substantially improving clinical pathways and patient care experience.